|
流感病毒传染性CBER-48A[A/悉尼/5/2021][H1N1]22/214
|
EA
|
22/214
|
咨询
|
1-4/12周
|
|
流感抗原A/悉尼/5/2021[SAN-013][H1N1]22/220
|
EA
|
22/220
|
4081
|
1-4/12周
|
|
人甲胎蛋白[第2批WHO国际标准]22/216
|
EA
|
22/216
|
4988
|
1-4/12周
|
|
流感抗A/悉尼/5/2021样[H1N1]HA血清22/224
|
EA
|
22/224
|
4081
|
1-4/12周
|
|
抗猴痘病毒抗体工作试剂22/218
|
EA
|
22/218
|
1846
|
1-4/12周
|
|
流感抗原A/悉尼/175/2022[IVR-235][H1N1]22/222
|
EA
|
22/222
|
4081
|
1-4/12周
|
|
流感病毒传染性A/悉尼/5/2021[H1N1]22/200
|
EA
|
22/200
|
咨询
|
1-4/12周
|
|
流感病毒传染性A/维多利亚/2570/2019[H1N1]NYMCX-37922/174
|
EA
|
22/174
|
咨询
|
1-4/12周
|
|
流感病毒传染性A/达尔文/22/2021[H3N2]NIB-13022/178
|
EA
|
22/178
|
咨询
|
1-4/12周
|
|
甲型流感病毒/贵州/柳枝特/326/2022[H3N2]CNIC-220622/180
|
EA
|
22/180
|
咨询
|
1-4/12周
|
|
WHO肠道微生物DNA提取国际参考试剂[全细胞]22/210
|
EA
|
22/210
|
4988
|
1-4/12周
|
|
传染性B型流感病毒/奥地利/1359417/2021[B-维多利亚谱系]BVR-2622/204
|
EA
|
22/204
|
咨询
|
1-4/12周
|
|
流感病毒传染性B/康涅狄格州/01/2021[B-维多利亚谱系]22/154
|
EA
|
22/154
|
咨询
|
1-4/12周
|
|
脑膜炎球菌荚膜Y组多糖22/148
|
EA
|
22/148
|
4502
|
1-4/12周
|
|
流感病毒传染性A/里昂/820/2021[H1N1]NIB-13222/172
|
EA
|
22/172
|
咨询
|
1-4/12周
|
|
流感病毒传染性A/挪威/16606/2021[H3N2]NYMCX-373A22/156
|
EA
|
22/156
|
咨询
|
1-4/12周
|
|
传染性流感病毒A/荷兰/00007/2021[H3N2]NYMCX-37722/158
|
EA
|
22/158
|
咨询
|
1-4/12周
|
|
流感病毒传染性A/布里斯班/02/2018[H1N1]22/146
|
EA
|
22/146
|
咨询
|
1-4/12周
|
|
流感病毒传染性A/悉尼/5/2021[H1N1]SAN-01322/142
|
EA
|
22/142
|
咨询
|
1-4/12周
|
|
传染性流感病毒A/荷兰00007/2021[H3N2]SAN-01222/140
|
EA
|
22/140
|
咨询
|
1-4/12周
|